{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:11:10Z","timestamp":1794118270010,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jaut.2023.103033","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T08:19:02Z","timestamp":1681892342000},"page":"103033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis"],"prefix":"10.1016","volume":"141","author":[{"given":"Serena","family":"Porcari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Severino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Rondinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bibb\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Quaranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Masucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Maida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Scaldaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Sanguinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cammarota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8318-0515","authenticated-orcid":false,"given":"Gianluca","family":"Ianiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2023.103033_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s11739-015-1366-6","article-title":"Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection","volume":"11","author":"Khanna","year":"2016","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jaut.2023.103033_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/egh.10.48","article-title":"The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings","volume":"4","author":"Khanna","year":"2010","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2023.103033_bib3","first-page":"S88","volume":"vol. 55","author":"Dubberke","year":"2012"},{"key":"10.1016\/j.jaut.2023.103033_bib4","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile--more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2023.103033_bib5","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1136\/gutjnl-2016-312297","article-title":"Antibiotics as deep modulators of gut microbiota: between good and evil","volume":"65","author":"Ianiro","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2023.103033_bib6","series-title":"Antibiotic Treatment for Clostridium Difficile-Associated Diarrhea in Adults","author":"Nelson","year":"2011"},{"issue":"Suppl 6","key":"10.1016\/j.jaut.2023.103033_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/1469-0691.12046","article-title":"Can we identify patients at high risk of recurrent Clostridium difficile infection?","volume":"18","author":"Kelly","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jaut.2023.103033_bib8","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","article-title":"Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease","volume":"97","author":"v McFarland","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2023.103033_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s11894-014-0393-1","article-title":"Managing Clostridium difficile in inflammatory bowel disease (IBD)","volume":"16","author":"Hashash","year":"2014","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.jaut.2023.103033_bib10","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1572-0241.2007.01780.x","article-title":"A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2023.103033_bib11","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s10620-014-3169-4","article-title":"The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease","volume":"59","author":"Hourigan","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2023.103033_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10071315","article-title":"Risk factors, diagnosis, and management of Clostridioides difficile infection in patients with inflammatory bowel disease","volume":"10","author":"del Vecchio","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.jaut.2023.103033_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2036.2012.05022.x","article-title":"Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease","volume":"35","author":"Ananthakrishnan","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2023.103033_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2023.103033_bib15","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.2174\/13816128113196660723","article-title":"Role of yeasts in healthy and impaired gut microbiota: the gut mycome","volume":"20","author":"Ianiro","year":"2014","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.jaut.2023.103033_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2014.12.006","article-title":"The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy","volume":"149","author":"Cammarota","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"2014","key":"10.1016\/j.jaut.2023.103033_bib17","article-title":"Role of microbiota and innate immunity in recurrent Clostridium difficile infection","author":"Bibb\u00f2","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaut.2023.103033_bib18","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1136\/gutjnl-2019-319548","article-title":"International consensus conference on stool banking for faecal microbiota transplantation in clinical practice","volume":"68","author":"Cammarota","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2023.103033_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2050640620967898","article-title":"A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group","volume":"9","author":"Keller","year":"2021","journal-title":"United European Gastroenterol J"},{"issue":"Suppl 2","key":"10.1016\/j.jaut.2023.103033_bib20","article-title":"European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults","volume":"27","author":"van Prehn","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jaut.2023.103033_bib21","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1053\/j.gastro.2018.12.019","article-title":"Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection","volume":"156","author":"Hvas","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2023.103033_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/L15-5139","article-title":"Decrease in surgery for Clostridium difficile infection after starting a program to transplant fecal microbiota","volume":"163","author":"Cammarota","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2023.103033_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7326\/M18-3635","article-title":"Incidence of bloodstream infections, length of hospital stay, and survival in patients with recurrent Clostridioides difficile infection treated with fecal microbiota transplantation or antibiotics: a prospective cohort study","volume":"171","author":"Ianiro","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2023.103033_bib24","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/ibd\/izaa283","article-title":"Inflammatory bowel disease outcomes following fecal microbiota transplantation for recurrent C. difficile infection","volume":"27","author":"Allegretti","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jaut.2023.103033_bib25","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1053\/j.gastro.2020.07.045","article-title":"Outcomes of fecal microbiota transplantation in patients with inflammatory bowel diseases and recurrent Clostridioides difficile infection","volume":"159","author":"Allegretti","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2023.103033_bib26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/ibd\/izz299","article-title":"Efficacy of fecal microbiota transplantation for recurrent C. Difficile infection in inflammatory bowel disease","volume":"26","author":"Tariq","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jaut.2023.103033_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cgh.2016.11.028","article-title":"Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease: a single-center experience","volume":"15","author":"Chin","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2023.103033_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1994834","article-title":"Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center","volume":"13","author":"Ianiro","year":"2021","journal-title":"Gut Microb."},{"key":"10.1016\/j.jaut.2023.103033_bib29","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2023.103033_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chron. Dis."},{"key":"10.1016\/j.jaut.2023.103033_bib31","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ibd.20520","article-title":"Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis","volume":"14","author":"Lewis","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jaut.2023.103033_bib32","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2023.103033_bib33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","article-title":"European consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2023.103033_bib34","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S2468-1253(20)30082-0","article-title":"Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel","volume":"5","author":"Ianiro","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2023.103033_bib35","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gutjnl-2020-321829","article-title":"Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic","volume":"69","author":"Ianiro","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2023.103033_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18127-y","article-title":"Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma","volume":"11","author":"Ianiro","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2023.103033_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","article-title":"Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Haifer","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2023.103033_bib37","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1177\/2050640618780762","article-title":"Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: a systematic review and meta-analysis","volume":"6","author":"Ianiro","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.jaut.2023.103033_bib39","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2023.103033_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2023.103033_bib41","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3390\/jcm9061757","article-title":"Fecal microbiota transplantation: screening and selection to choose the optimal donor","volume":"9","author":"Bibb\u00f2","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jaut.2023.103033_bib42","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s41591-022-01964-3","article-title":"Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases","volume":"28","author":"Ianiro","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2023.103033_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apt.16148","article-title":"Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020","volume":"53","author":"Marcella","year":"2021","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:35:29Z","timestamp":1760258129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841123000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":43,"alternative-id":["S0896841123000422"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103033","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103033"}}